Pluripotent stem cell-derived CD19-CAR iT cells effectively eradicate B-cell lymphoma in vivo

Cell Mol Immunol. 2021 Mar;18(3):773-775. doi: 10.1038/s41423-020-0429-4. Epub 2020 Jun 15.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigens, CD19 / immunology*
  • Core Binding Factor Alpha 2 Subunit / metabolism
  • Hematopoietic Stem Cells / cytology
  • Hematopoietic Stem Cells / metabolism
  • Homeodomain Proteins / metabolism
  • Immunotherapy, Adoptive / methods*
  • Lymphoma, B-Cell / immunology
  • Lymphoma, B-Cell / metabolism
  • Lymphoma, B-Cell / therapy*
  • Mice
  • Mice, Inbred C57BL
  • Pluripotent Stem Cells / cytology*

Substances

  • Antigens, CD19
  • Core Binding Factor Alpha 2 Subunit
  • Homeodomain Proteins
  • Runx1 protein, mouse
  • homeobox protein HOXA9